All News #Library
Biotech
HepaRegeniX Completes Phase Ib HRX-215 Liver Study
11 Feb 2026 //
GLOBENEWSWIRE
HepaRegeniX secures €21.5M for HRX-215 liver regeneration
15 Apr 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support